Curcumin-loaded hydroxypropyl-β-cyclodextrin inclusion complex with enhanced dissolution and oral bioavailability for epilepsy treatment

References

• Abdulmalek S, Nasef M, Awad D, Balbaa M. 2021. Protective effect of natural antioxidant, curcumin nanoparticles, and zinc oxide nanoparticles against type 2 diabetes-promoted hippocampal neurotoxicity in rats. Pharmaceutics. 13(11):1937.
   PubMed Web of Science ®Google Scholar
• Agarwal NB, Jain S, Nagpal D, Agarwal NK, Mediratta PK, Sharma KK. 2013. Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundam Clin Pharmacol. 27(2):169–172.
   PubMed Web of Science ®Google Scholar
• Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A. 2008. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain. 131(Pt 12):3256–3265.
   PubMed Web of Science ®Google Scholar
• Boarescu PM, Boarescu I, Bocsan IC, Gheban D, Bulboaca AE, Nicula C, Pop RM, Rajnoveanu RM, Bolboaca SD. 2019. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants-Basel. 8(10):504.
   Web of Science ®Google Scholar
• Choudhary KM, Mishra A, Poroikov VV, Goel RK. 2013. Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol. 704(1–3):33–40.
   PubMed Web of Science ®Google Scholar
• Dhir A. 2018. Curcumin in epilepsy disorders. Phytother Res. 32(10):1865–1875.
   PubMed Web of Science ®Google Scholar
• Drion CM, van Scheppingen J, Arena A, Geijtenbeek KW, Kooijman L, van Vliet EA, Aronica E, Gorter JA. 2018. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo – in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. J Neuroinflamm. 15:212.
   PubMed Web of Science ®Google Scholar
• Ezz HSA, Khadrawy YA, Noor NA. 2011. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem Res. 36(11):2195–2204.
   PubMed Web of Science ®Google Scholar
• Gould S, Scott RC. 2005. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. Food Chem Toxicol. 43(10):1451–1459.
   PubMed Web of Science ®Google Scholar
• Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G. 2016. Nanoparticle transport across the blood brain barrier. Tissue Barriers. 4(1):e1153568.
   PubMed Web of Science ®Google Scholar
• Grama CN, Suryanarayana P, Patil MA, Raghu G, Balakrishna N, Kumar MNVR, Reddy GB. 2013. Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. PLOS One. 8(10):e78217.
   PubMed Web of Science ®Google Scholar
• Gupta NK, Dixit VK. 2011. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J Pharm Sci. 100(5):1987–1995.
   PubMed Web of Science ®Google Scholar
• Haley RM, Gottardi R, Langer R, Mitchell MJ. 2020. Cyclodextrins in drug delivery: applications in gene and combination therapy. Drug Deliv Transl Res. 10(3):661–677.
   PubMed Web of Science ®Google Scholar
• Hashemian M, Anissian D, Ghasemi-Kasman M, Akbari A, Khalili-Fomeshi M, Ghasemi S, Ahmadi F, Moghadamnia AA, Ebrahimpour A. 2017. Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):462–471.
   PubMed Web of Science ®Google Scholar
• He Y, Liu H, Bian W, Liu Y, Liu X, Ma S, Zheng X, Du Z, Zhang K, Ouyang D. 2019. Molecular interactions for the curcumin-polymer complex with enhanced anti-inflammatory effects. Pharmaceutics. 11(9):442.
   PubMed Web of Science ®Google Scholar
• Heidari S, Mahdiani S, Hashemi M, Kalalinia F. 2020. Recent advances in neurogenic and neuroprotective effects of curcumin through the induction of neural stem cells. Biotechnol Appl Biochem. 67(3):430–441.
   PubMed Web of Science ®Google Scholar
• Hong W, Gao Y, Lou B, Ying S, Wu W, Ji X, Yu N, Jiao Y, Wang H, Zhou X, et al. 2021. Curcumin-loaded hybrid nanoparticles: microchannel-based preparation and antitumor activity in a mouse model. Int J Nanomed. 16:4147–4159.
   PubMed Web of Science ®Google Scholar
• Huang R, Zhu Y, Lin L, Song S, Cheng L, Zhu R. 2020. Solid lipid nanoparticles enhanced the neuroprotective role of curcumin against epilepsy through activation of Bcl-2 family and P38 MAPK pathways. ACS Chem Neurosci. 11(13):1985–1995.
   PubMed Web of Science ®Google Scholar
• Huo X, Zhang Y, Jin X, Li Y, Zhang L. 2019. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer’s disease. J Photochem Photobiol B. 190:98–102.
   PubMed Web of Science ®Google Scholar
• Kiss K, Hegedüs K, Vass P, Vári-Mező D, Farkas A, Nagy ZK, Molnár L, Tóvári J, Mező G, Marosi G. 2022. Development of fast-dissolving dosage forms of curcuminoids by electrospinning for potential tumor therapy application. Int J Pharm. 611:121327.
   PubMed Web of Science ®Google Scholar
• Li N, Wang N, Wu T, Qiu C, Wang X, Jiang S, Zhang Z, Liu T, Wei C, Wang T. 2018. Preparation of curcumin-hydroxypropyl-beta-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Drug Dev Ind Pharm. 44(12):1966–1974.
   PubMed Web of Science ®Google Scholar
• Mangolim CS, Moriwaki C, Nogueira AC, Sato F, Baesso ML, Neto AM, Matioli G. 2014. Curcumin-beta-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application. Food Chem. 153:361–370.
   PubMed Web of Science ®Google Scholar
• Mehla J, Reeta KH, Gupta P, Gupta YK. 2010. Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci. 87(19–22):596–603.
   PubMed Web of Science ®Google Scholar
• Naqvi S, Panghal A, Flora SJS. 2020. Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front Neurosci. 14:494.
   PubMed Web of Science ®Google Scholar
• Preetha Anand ABK, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin problems and promises. Mol Pharm. 4: 807–818.
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Al Shaal L, Muller RH, Keck CM. 2013. Development of curcumin nanocrystal: physical aspects. J Pharm Sci. 102(1):204–214.
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Budiputra DK, Mauludin R. 2015. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm. 41(4):560–566.
   PubMed Web of Science ®Google Scholar
• Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, et al. 2018. Protective effects of Indian spice curcumin against amyloid-beta in Alzheimer’s disease. J Alzheimers Dis. 61(3):843–866.
   PubMed Web of Science ®Google Scholar
• Santana-Gomez CE, Engel J, Staba R. 2022. Drug-resistant epilepsy and the hypothesis of intrinsic severity: what about the high-frequency oscillations? Epilepsia Open. 7(S1):S59–S67.
   PubMedGoogle Scholar
• Seo SW, Han HK, Chun MK, Choi HK. 2012. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol(R) HS15 as a carrier. Int J Pharm. 424(1–2):18–25.
   PubMed Web of Science ®Google Scholar
• Sun M, Zhao L, Guo C, Cao F, Chen H, Zhao L, Tan Q, Zhu X, Zhu F, Ding T, et al. 2012. Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles. J Nanopart Res. 14(2): 9141–9146.
   Web of Science ®Google Scholar
• Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. 2009. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem. 57(19):9141–9146.
   PubMed Web of Science ®Google Scholar
• Tsai YM, Chang-Liao WL, Chien CF, Lin LC, Tsai TH. 2012. Effects of polymer molecular weight on relative oral bioavailability of curcumin. Int J Nanomedicine. 7:2957–2966.
   PubMed Web of Science ®Google Scholar
• Tsai YM, Chien CF, Lin LC, Tsai TH. 2011. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. 416(1):331–338.
   PubMed Web of Science ®Google Scholar
• Villaflores OB, Chen Y-J, Chen C-P, Yeh J-M, Wu T-Y. 2012. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer’s disease. Taiwan J Obstet Gynecol. 51(4):554–564.
   PubMed Web of Science ®Google Scholar
• Walker LE, Sills GJ, Jorgensen A, Alapirtti T, Peltola J, Brodie MJ, Marson AG, Vezzani A, Pirmohamed M. 2022. High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: a proof-of-concept study. Epilepsia. 63(1):E1–E6.
   PubMed Web of Science ®Google Scholar
• Xie XX, Tao Q, Zou YN, Zhang FY, Guo M, Wang Y, Wang H, Zhou Q, Yu SQ. 2011. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 59(17):9280–9289.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. 2010. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 79(1):113–125.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang S, Wong LR, Xie H, Ho PC. 2020. In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin/hydroxypropyl-beta-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer’s disease. Mol Pharm. 17(11):4256–4269.
   PubMed Web of Science ®Google Scholar